KAITLYN GILSENAN: Open Payments
NPI 1932782489 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,513 in 25 payments from 7 companies in 2025. Trend: 2023 $866 · 2024 $528 · 2025 $2,513
Food & beverage: $1,299Travel & lodging: $1,214
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 19 | $1,897 |
| Amgen Inc. | 1 | $145 |
| Gilead Sciences, Inc. | 1 | $139 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $115 |
| ABBVIE INC. | 1 | $113 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $86 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: INSPIRE, UBRELVY, XIFAXAN, NUCALA.
Industry payments across PA — which companies pay providers there.
